BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29545079)

  • 1. Osteonecrosis of the jaw unrelated to medication or radiotherapy.
    Gadiwalla Y; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):446-453. PubMed ID: 29545079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
    Grisar K; Schol M; Schoenaers J; Dormaar T; Coropciuc R; Vander Poorten V; Politis C
    Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New cancer therapies and jaw necrosis.
    Patel V; Kelleher M; Sproat C; Kwok J; McGurk M
    Br Dent J; 2015 Sep; 219(5):203-7. PubMed ID: 26361116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents.
    Zadik Y; Ganor Y; Rimon O; Bersudski E; Meirovitz A
    Radiother Oncol; 2021 Mar; 156():275-280. PubMed ID: 33373641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
    Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiologic diagnosis of jaw osteonecrosis, other than bisphosphonate and radiotherapy related osteitis].
    Magremanne M; Picheca S; Reychler H
    Rev Stomatol Chir Maxillofac Chir Orale; 2014 Feb; 115(1):e1-7. PubMed ID: 24456912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiologic diagnosis of jaw osteonecrosis, other than bisphosphonate and radiotherapy related osteonecrosis.
    Magremanne M; Picheca S; Reychler H
    Rev Stomatol Chir Maxillofac Chir Orale; 2014 Feb; 115(1):45-50. PubMed ID: 24456913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer: comprehending the condition, causes, controversies, control and consequences. 17. Osteonecrosis.
    Madrid C; Scully C
    Dent Update; 2012 Jun; 39(5):377-9. PubMed ID: 22852516
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteonecrosis of the jaw and dental extractions: A single-center experience.
    Sandhu S; Salous MH; Sankar V; Margalit DN; Villa A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):515-521. PubMed ID: 32723683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates and osteonecrosis of the jaw.
    Sambrook P; Olver I; Goss A
    Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and eventual adjuvant treatment: The potential role of chemotherapy.
    Lai TY; Wang TH; Liu CJ; Chao TF; Chen TJ; Hu YW
    Radiother Oncol; 2017 Jun; 123(3):406-411. PubMed ID: 28532609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-Related Osteonecrosis of the Jaws.
    Migliorati CA; Brennan MT; Peterson DE
    J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
    J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New foundations in understanding osteonecrosis of the jaws.
    Assael LA
    J Oral Maxillofac Surg; 2004 Feb; 62(2):125-6. PubMed ID: 14762742
    [No Abstract]   [Full Text] [Related]  

  • 16. Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw.
    Li J; Wang W
    J Stomatol Oral Maxillofac Surg; 2020 Jun; 121(3):264-267. PubMed ID: 31863928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
    Fusco V; Santini D; Armento G; Tonini G; Campisi G
    Expert Opin Drug Saf; 2016 Jul; 15(7):925-35. PubMed ID: 27074901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D (25-OHD) deficiency may increase the prevalence of medication-related osteonecrosis of the jaw.
    Heim N; Warwas FB; Wilms CT; Reich RH; Martini M
    J Craniomaxillofac Surg; 2017 Dec; 45(12):2068-2074. PubMed ID: 29102331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the Jaw in the Absence of Antiresorptive or Antiangiogenic Exposure: A Series of 6 Cases.
    Aghaloo TL; Tetradis S
    J Oral Maxillofac Surg; 2017 Jan; 75(1):129-142. PubMed ID: 27569557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.